Established in 2010, AMTA is an advanced and independent specialty generic drug product development firm, focusing on the innovative controlled-release/
extended-release oral solid dosage forms. AMTA provides product formulation development, analytical development, regulatory CMC, and commercial process development consulting service.
What we do
Co-development: AMTA team focuses on producing high entry-value and complex generics. If you are looking for reliable partners, please contact us.
License Out: AMTA is the intellectual property owner of several product dossiers that are open for license out and marketing authorization in different markets.
With more than 20 products under development or filed with regulatory agency in the US, AMTA will continue to build on its portfolio over the coming years.
AMTA LABS LIMITED
